Elizabeth Mullen

Dr. Elizabeth Mullen is an Assistant Professor of Pediatrics at Harvard Medical School and an Attending Physician at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Her clinical and research focus centers on pediatric kidney tumors, particularly Wilms tumor and related malignancies.

• Yale University School of Medicine, MD (1992)
• Boston Children's Hospital, Pediatrics Internship (1993)
• Boston Combined Residency Program, Pediatrics Residency (1995)
• Dana-Farber/Boston Children's, Pediatric Hematology-Oncology Fellowship (1997)

Her research explores genetic and epigenetic factors in bilateral Wilms tumor predisposition, chemotherapy resistance mechanisms, and molecular profiling of pediatric renal cancers. She contributes to Children's Oncology Group (COG) studies evaluating treatment outcomes, imaging protocols, and biomarker development for pediatric kidney malignancies.

Recent publications highlight her work on genomic alterations (1p/16q LOH, TRIP13), DICER1-associated tumors, and precision therapy approaches in high-risk Wilms tumor. Her clinical practice emphasizes pediatric hematology-oncology care with specific interest in renal tumor biology and oncologic emergencies.

Contact:

• Tel: 888-733-4662
• Fax: 617-632-5710
• Email: p edi_onc@dfci.harvard.edu